Authors: OPAL SM FISHER CJ DHAINAUT JFA VINCENT JL BRASE R LOWRY SF SADOFF JC SLOTMAN GJ LEVY H BALK RA SHELLY MP PRIBBLE JP LABRECQUE JF LOOKABAUGH J DONOVAN H DUBIN H BAUGHMAN R NORMAN J DEMARIA E MATZEL K ABRAHAM E SENEFF M BARBER A BRAYMAN K CERRA F CHALFIN D CHAZEN G CHRISTOU N COONEY R CORBIN R DREW R EMMANUEL G PINES B ERON L FLETCHER R FOULKE G GALLAGHER T GERVICH D GROSSMAN J HALPERN N HANNA C JOHNSON S KUBAK B LODATO R LOVETT M MARSHALL J METZLER M NELSON L FREELAND M OROPELLO J PAZ H RACKOW E RIKER R RISSING P SCHEIN R SCHELD M SCHUSTER D SIBBALD W SILVERMAN H SOMERMEYER M STRANGE C SUMMER W TOPIEL M WHITE J ALESTIG K ANDERSEN PK ANDERSSON J BENNETT D BERG S BLEICHNER G BRUNET F CARLET J DEJONG MJ DREXLER H GARRARD C HESLET L KLOSS T PAUL W REINHART K RENAUD B RITZ R ROMME JH SCHMITZ JE STOCKENHUBER F SUTER P TENAILLON A VAGT A VANDERMEER WM VANDEVENTER S VANLEEUWEN PAM VERHOEF J WEBSTER N WINTER RJ WOLFF M STILES DM DEVOS A CROFT C FAZIO J THOMPSON R WIEDEMANN H ELLISON RT CHINCHILLI VM YARBOROUGH M

Citation: Sm. Opal et al., CONFIRMATORY INTERLEUKIN-1 RECEPTOR ANTAGONIST TRIAL IN SEVERE SEPSIS- A PHASE-III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL, Critical care medicine, 25(7), 1997, pp. 1115-1124